Status:
COMPLETED
Extension for Community Health Outcomes (ECHO) Diabetes Program
Lead Sponsor:
University of Florida
Conditions:
Type 1 Diabetes
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Project ECHO model is currently used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach using a "hub" and "spoke" learning model. Few studies ...
Detailed Description
The recruitment of spokes for the ECHO Diabetes program was accomplished by focusing on FQHC (and FQHC look-alikes) through use of the Neighborhood Deprivation Index coupled with provider geocoding. T...
Eligibility Criteria
Inclusion
- Age 18 and older
- Seen for routine care at participating FQHC
- Diagnosis of Type 1 Diabetes or Type 2 Diabetes
Exclusion
- • Not meeting all inclusion criteria
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
32796 Patients enrolled
Trial Details
Trial ID
NCT06552923
Start Date
June 1 2021
End Date
December 31 2023
Last Update
August 14 2024
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
CommuniCare Davis Family Health Center
Davis, California, United States, 95616
2
St Agnes Medical Center
Fresno, California, United States, 93720
3
La Clinica
Multiple Locations, California, United States, 94601
4
Santa Rosa Community Health Centers
Multiple Locations, California, United States, 95403